Targeted Near-Infrared Fluorescent Turn-on Nanoprobe for Activatable Imaging and Effective Phototherapy of Cancer Cells
Source abstract
Abstract
A novel and green multifunctional nanoplatform as a nanocarrier for drug delivery, cell imaging, and phototherapy has been engineered. The nanoplatform is composed of stabilized carbon spheres (CSs) as cores, a coated polydopamine (PDA) shell, targeted folic acid (FA), and the loaded anticancer drug indocyanine green (ICG), obtaining CSs@PDA-FA@ICG nanocomposites (NCs). The biocompatible PDA shell provided a high fluorescence quenching efficiency and a surface rich in functional groups for anchoring FA for targeting cancer cells. Aromatic ICG could be effectively loaded into the CSs@PDA-FA system via hydrophobic interactions and π-π stacking with a loading efficiency of 58.9%. Notably, the activated NIR fluorescence in an intracellular environment made CSs@PDA-FA@ICG a sensitive "OFF" to "ON" nanoprobe that can be used for NIR imaging. Moreover, compared to ICG alone, the CSs@PDA-FA@ICG NCs could induce efficient photoconversion for simultaneous synergetic photodynamic therapy (PDT) and photothermal therapy (PTT) under a single NIR laser irradiation. The results demonstrated that CSs@PDA-FA@ICG NCs as a targeted and activated nanoplatform provide new opportunities to facilitate the accurate diagnosis of cancer and enhanced treatment efficacy. This work stimulates more interest in the design of the facile surface functionalization strategy to construct other multifunctional nanocomposites, such as nanotubes and nanorods.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Agricultural Microbiology, College of Science, College of Food Science and Technology, Huazhong Agricultural University, Wuhan 430070, P. R. China
Funding
Ministry of Education of the People's Republic of China · National Natural Science Foundation of China
References (45)
Show source-provided references
1. Lee D.-E. · Chem. Soc. Rev. · 2012 · 41 · 265610.1039/C2CS15261D ↗
2. Skeete Z. · ACS Appl. Mater. Interfaces · 2014 · 6 · 2175210.1021/am502693t ↗
3. Chen Z. · Adv. Funct. Mater. · 2014 · 24 · 52210.1002/adfm.201301951 ↗
4. Monaco A. M. · Beilstein J. Nanotechnol. · 2014 · 5 · 184910.3762/bjnano.5.196 ↗
5. Gong H. · Adv. Drug Delivery Rev. · 2013 · 65 · 195110.1016/j.addr.2013.10.002 ↗
6. Kim T.-W. · Nano Lett. · 2008 · 8 · 372410.1021/nl801976m ↗
7. Li M. · Carbohyd. Res. · 2011 · 346 · 99910.1016/j.carres.2011.03.020 ↗
8. Fang Y. · Angew. Chem., Int. Ed. · 2010 · 49 · 798710.1002/anie.201002849 ↗
9. Liu X. · RSC Adv. · 2015 · 5 · 1753210.1039/C4RA16359A ↗
10. Xu G. · RSC Adv. · 2014 · 4 · 3398610.1039/C4RA03993A ↗
11. Zhou L. · Carbon · 2015 · 82 · 47910.1016/j.carbon.2014.10.091 ↗
12. Wan L. · Carbon · 2014 · 79 · 12310.1016/j.carbon.2014.07.050 ↗
13. Lin L. · ACS Nano · 2014 · 8 · 387610.1021/nn500722y ↗
14. Black K. C. · Nanomedicine · 2013 · 8 · 1710.2217/nnm.12.82 ↗
15. Liu X. · ACS Nano · 2013 · 7 · 938410.1021/nn404117j ↗
16. Lee H. · Adv. Mater. · 2009 · 21 · 43110.1002/adma.200801222 ↗
17. Liu Y. · Adv. Mater. · 2013 · 25 · 135310.1002/adma.201204683 ↗
18. Yang S. J. · Bioconjugate Chem. · 2010 · 21 · 67910.1021/bc9004798 ↗
19. Chen N. · ACS Appl. Mater. Interfaces · 2014 · 6 · 1985010.1021/am505223t ↗
20. Sheng Z. · ACS Nano · 2014 · 8 · 1231010.1021/nn5062386 ↗
21. Mizrahi D. M. · Eur. J. Med. Chem. · 2011 · 46 · 517510.1016/j.ejmech.2011.08.040 ↗
22. Ma Y. · Int. J. Pharm. · 2012 · 436 · 2510.1016/j.ijpharm.2012.06.007 ↗
23. Zheng X. · Mol. Pharmaceutics · 2012 · 9 · 51410.1021/mp200526m ↗
24. Yu J. · J. Am. Chem. Soc. · 2010 · 132 · 192910.1021/ja908139y ↗
25. Altinoglu E. I. · ACS Nano · 2008 · 2 · 207510.1021/nn800448r ↗
26. Hannah A. · ACS Nano · 2014 · 8 · 25010.1021/nn403527r ↗
27. Wang Y. · Small · 2014 · 10 · 10910.1002/smll.201301297 ↗
28. Wen H. · Small · 2012 · 8 · 76010.1002/smll.201101613 ↗
29. Huang P. · Theranostics · 2011 · 1 · 24010.7150/thno/v01p0240 ↗
30. Zheng M. · ACS Nano · 2013 · 7 · 205610.1021/nn400334y ↗
31. Kirchherr A. K. · Mol. Pharmaceutics · 2009 · 6 · 48010.1021/mp8001649 ↗
32. Jia X. · ACS Appl. Mater. Interfaces · 2015 · 7 · 457910.1021/am507443p ↗
33. Yin L. Y. · Toxicon · 2005 · 46 · 50710.1016/j.toxicon.2005.06.015 ↗
34. Mahmood M. · J. Mater. Chem. B · 2013 · 1 · 322010.1039/c3tb20248h ↗
35. Kakran M. · Curr. Med. Chem. · 2011 · 18 · 450310.2174/092986711797287548 ↗
36. Zhang Y. · ACS Nano · 2010 · 4 · 318110.1021/nn1007176 ↗
37. Hu W. · ACS Nano · 2011 · 5 · 369310.1021/nn200021j ↗
38. Zhao P. · Eur. J. Pharm. Biopharm. · 2012 · 80 · 53510.1016/j.ejpb.2011.12.002 ↗
39. Hong S. · Nanomedicine · 2011 · 6 · 79310.2217/nnm.11.76 ↗
40. Liu X. · ACS Nano · 2013 · 7 · 938410.1021/nn404117j ↗
41. Sheng Z. · Nano-Micro Lett. · 2013 · 5 · 14510.1007/BF03353743 ↗
42. Saxena V. · Int. J. Pharm. · 2006 · 308 · 20010.1016/j.ijpharm.2005.11.003 ↗
43. Lee S. · Chem. Commun. (Cambridge, U.K.) · 2008 · 36 · 425010.1039/b806854m ↗
44. Lee S. · Nano Lett. · 2009 · 9 · 4423
45. Liu P. · Chem. Commun. (Cambridge, U.K.) · 2013 · 49 · 614310.1039/c3cc43633k ↗